Tranexamic Acid (TXA) in Trauma Patients: Barriers to Use among Trauma Surgeons and Emergency Physicians
Objective. Tranexamic Acid (TXA) is currently the only drug with prospective clinical evidence supporting its use in bleeding trauma patients. We sought to better understand the barriers preventing its use and elicit suggestions to further its use in trauma patients in the state of Maryland. Methods...
Main Author: | Abdulaziz Alburaih |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Emergency Medicine International |
Online Access: | http://dx.doi.org/10.1155/2017/4235785 |
Similar Items
-
TXA (Tranexamic Acid) Risk Evaluation in Combat Casualties (TRECC)
by: Kathleen E Adair, et al.
Published: (2020-12-01) -
Surgeons’ and Emergency Physicians’ Perceptions of Trauma Management and Training
by: Hemphill, Robin R, et al.
Published: (2009-08-01) -
Tranexamic acid in trauma-induced coagulopathy
by: Ratković Sanja, et al.
Published: (2021-01-01) -
Geographical Variance in the Use of Tranexamic Acid for Major Trauma Patients
by: Kieran Walsh, et al.
Published: (2019-09-01) -
Tranexamic Acid; A Glittering Player in the Field of Trauma
by: Fariborz Ghaffarpasand, et al.
Published: (2020-04-01)